• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

莫德纳信使核糖核酸-1273新冠疫苗接种后出现多发性角化棘皮瘤，经5-氟尿嘧啶治疗后痊愈：病例报告

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report.

作者信息

Ahmed Fahad, Memon Nashwah, Haque Adel

机构信息

Department of Dermatology Perelman School of Medicine University of Pennsylvania Philadelphia, PA United States.

Lake Erie College of Osteopathic Medicine Bradenton, FL United States.

出版信息

JMIR Dermatol. 2022 Dec 1;5(4):e41739. doi: 10.2196/41739. eCollection 2022 Oct-Dec.

DOI:10.2196/41739
PMID:36504544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9720466/
Abstract

Cutaneous reactions have been commonly associated with the Moderna messenger RNA (mRNA) COVID-19 vaccine. Among the reported cutaneous side effects, there have not been any associations reported yet regarding keratoacanthoma development after COVID-19 mRNA vaccination. We report a novel case of an 86-year-old man who experienced an eruption of multiple keratoacanthomas 2 weeks after inoculation with the Moderna mRNA-1273 vaccine that resolved following treatment with intralesional 5-fluorouracil.

摘要

皮肤反应通常与莫德纳信使核糖核酸（mRNA）新冠疫苗有关。在报告的皮肤副作用中，尚未有关于新冠mRNA疫苗接种后发生角化棘皮瘤的相关报道。我们报告了一例新病例，一名86岁男性在接种莫德纳mRNA-1273疫苗后2周出现多发性角化棘皮瘤皮疹，经皮损内注射5-氟尿嘧啶治疗后消退。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/b5236390f691/derma_v5i4e41739_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/3d366e6abe43/derma_v5i4e41739_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/63660487d623/derma_v5i4e41739_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/96f80efeac6a/derma_v5i4e41739_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/b5236390f691/derma_v5i4e41739_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/3d366e6abe43/derma_v5i4e41739_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/63660487d623/derma_v5i4e41739_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/96f80efeac6a/derma_v5i4e41739_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2413/11378736/b5236390f691/derma_v5i4e41739_fig4.jpg

相似文献

1
Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report.莫德纳信使核糖核酸-1273新冠疫苗接种后出现多发性角化棘皮瘤，经5-氟尿嘧啶治疗后痊愈：病例报告
JMIR Dermatol. 2022 Dec 1;5(4):e41739. doi: 10.2196/41739. eCollection 2022 Oct-Dec.
2
Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.新型冠状病毒病信使核糖核酸疫苗接种后出现玫瑰糠疹样皮疹：一例病例报告及文献复习
JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.
3
Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine.接种 Moderna 新冠疫苗第一针后，BCG 疫苗接种疤痕激活。
Cutis. 2022 Mar;109(3):148-149. doi: 10.12788/cutis.0470.
4
Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.mRNA-1273（莫德纳）新冠疫苗接种后 Vogt-Koyanagi-Harada 病。
Ocul Immunol Inflamm. 2022 Jul;30(5):1250-1254. doi: 10.1080/09273948.2022.2053547. Epub 2022 Apr 11.
5
Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report.第二剂mRNA-1273（Moderna）新冠疫苗接种后出现大疱性药疹：病例报告
J Infect Public Health. 2021 Oct;14(10):1392-1394. doi: 10.1016/j.jiph.2021.06.021. Epub 2021 Jul 8.
6
Unusual arm vein thrombosis after the Moderna (mRNA-1273) COVID-19 vaccination-a case report.接种 Moderna（mRNA-1273）新冠疫苗后出现罕见手臂静脉血栓病例报告。
Ann Palliat Med. 2022 Nov;11(11):3567-3570. doi: 10.21037/apm-22-343. Epub 2022 Jun 28.
7
A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report.一例接种 COVID-19 疫苗后出现迟发性周围性面神经麻痹的 Miller Fisher 综合征：病例报告。
BMC Neurol. 2022 Aug 22;22(1):309. doi: 10.1186/s12883-022-02838-4.
8
Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report.与 Moderna COVID-19 疫苗相关的急性头晕和精神改变：一例报告。
BMC Neurol. 2022 Aug 26;22(1):322. doi: 10.1186/s12883-022-02834-8.
9
Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.成功非手术治疗切除难治性发疹性角化棘皮瘤。
Dermatol Online J. 2020 Mar 15;26(3):13030/qt0g36s6sp.
10
Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.基于人群的急性发作 COVID-19 mRNA 疫苗接种相关过敏反应的发生率、严重程度及相关风险因素。
J Allergy Clin Immunol Pract. 2022 Mar;10(3):827-836. doi: 10.1016/j.jaip.2021.12.021. Epub 2021 Dec 29.

引用本文的文献

1
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm.与遗传综合征相关的多发性角化棘皮瘤：叙述性综述及诊断算法建议
Am J Clin Dermatol. 2025 Jan;26(1):45-59. doi: 10.1007/s40257-024-00900-0. Epub 2024 Nov 21.
2
Generalized Eruptive Keratoacanthoma (GEKA) after Pfizer mRNABNT162b2 (Comirnaty) COVID-19 Vaccination Successfully Treated with Cemiplimab.辉瑞 mRNA（BNT162b2，Comirnaty）COVID-19 疫苗接种后发生泛发性发疹性角化棘皮瘤（GEKA），成功用西普利单抗治疗。
Viruses. 2024 Aug 6;16(8):1260. doi: 10.3390/v16081260.
3
Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma.

本文引用的文献

1
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.报告的 Moderna 和辉瑞 COVID-19 疫苗接种后皮肤反应：基于登记的 414 例病例研究。
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
2
Intralesional 5-fluorouracil for the treatment of squamous cell carcinomas.瘤内注射5-氟尿嘧啶治疗鳞状细胞癌。
J Am Acad Dermatol. 2021 Jun;84(6):1696-1697. doi: 10.1016/j.jaad.2020.12.049. Epub 2020 Dec 27.
3
Estimates of the severity of coronavirus disease 2019: a model-based analysis.
侵袭性皮肤鳞状细胞癌的瘤内治疗
Cancers (Basel). 2023 Dec 28;16(1):158. doi: 10.3390/cancers16010158.
新型冠状病毒疾病 2019 严重程度的估计：基于模型的分析。
Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30.
4
Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.与帕博利珠单抗治疗相关的爆发性角化棘皮瘤
JAMA Dermatol. 2017 Jul 1;153(7):694-697. doi: 10.1001/jamadermatol.2017.0989.
5
Eruptive Keratoacanthomas Associated With Leflunomide.与来氟米特相关的发疹性角化棘皮瘤
JAMA Dermatol. 2016 Jan;152(1):105-6. doi: 10.1001/jamadermatol.2015.2506.
6
Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway.与维莫非尼及BRAF通路抑制相关的皮肤毒性作用
Arch Dermatol. 2012 May;148(5):628-33. doi: 10.1001/archdermatol.2012.125.
7
Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma.氟尿嘧啶/肾上腺素可注射凝胶瘤内化疗：皮肤鳞状细胞癌的非手术治疗
J Am Acad Dermatol. 1998 Mar;38(3):438-42. doi: 10.1016/s0190-9622(98)70502-x.
8
Keratoacanthoma following pneumococcal vaccination: a case report.肺炎球菌疫苗接种后发生的角化棘皮瘤：一例报告
J Dermatol Surg Oncol. 1983 May;9(5):381-2. doi: 10.1111/j.1524-4725.1983.tb00820.x.
9
Keratoacanthoma in a smallpox vaccination site.天花疫苗接种部位的角化棘皮瘤。
Br J Dermatol. 1974 Jun;90(6):689-90. doi: 10.1111/j.1365-2133.1974.tb06699.x.